Inventor · disambiguated record
Zoltan Szilvassy
Also filed as: SZILVASSY ZOLTAN
4 granted patents·8 pending applications·2 citations·filing 2001–2015
59Inventor score
Top patents by PatentIndex Score
12 records- 0169US7763601B2Prevention and treatment of obesityN GENE RES LAB INC·Filed 2007·Granted Jul 27, 2010·2 cites·3 claims
- 0261US8048873B2Synergistic pharmaceutical combination for the prevention or treatment of diabetesN GENE RES LAB INC·Filed 2009·Granted Nov 1, 2011·0 cites·5 claims
- 0359US7767694B2Pharmaceutical composition having prokinetic effectN GENE RES LAB INC·Filed 2009·Granted Aug 3, 2010·0 cites·7 claims
- 0455US2009281143A1Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or ObesityN GENE RES LAB INC·Filed 2008·Application pending·0 cites
- 0552US2008108602A1Prevention of obesity in antipsychotic, antidepressant and antiepileptic medicationN GENE RES LAB INC·Filed 2007·Application pending·0 cites
- 0648US7635674B2Synergistic pharmaceutical combination for the prevention or treatment of diabetesN GENE RES LAB INC·Filed 2002·Granted Dec 22, 2009·0 cites·4 claims
- 0743US2010311719A1Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationN GENE RES LAB INC·Filed 2010·Application pending·0 cites
- 0841US2015366852A1Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationN GENE RES LAB INC·Filed 2015·Application pending·0 cites
- 0938US2012129769A1Orally administerable pharmaceutical preparation containing insulinSZILVASSY ZOLTAN·Filed 2010·Application pending·0 cites
- 1036US2007281972A1Pharmaceutical Composition Having Prokinetic EffectN GENE RES LAB INC·Filed 2005·Application pending·0 cites
- 1133US2004068005A1Pharmaceutical combinationsFiled 2001·Application pending·0 cites
- 1228US2009054487A1Pharmaceutical composition for increasing the mitochondrial genesisKOLONICS ATTILA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zoltan Szilvassy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →